Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

References

Page 1

	Year	Citations
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Nicolas Mottet, Joaquim Bellmunt, M. Bolla, European Urology Surgical OncologyUrologyCurative IntentGenitourinary CancerMedicine	2016	3.2K
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, New England Journal of Medicine	2015	2.7K
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Mack Roach, Gerald E. Hanks, Howard D. Thames, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineUrologyRadiation TherapyGenitourinary CancerMedicine	2006	2.7K
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer Karim Fizazi, NamPhuong Tran, Luis Fein, New England Journal of Medicine	2017	2.1K
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, The Lancet	2015	1.9K
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial M. Bolla, Laurence Collette, L.E.C.M. Blank, The Lancet UrologyGenitourinary CancerMedicinePhase IiiExternal Irradiation	2002	1.7K
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer Philip Cornford, Joaquim Bellmunt, M. Bolla, European Urology Surgical OncologyUrologyGenitourinary CancerMedicineCancer Management	2016	1.4K
The evolutionary history of lethal metastatic prostate cancer Nature UrologyEvolutionary HistoryGenitourinary CancerEvolutionary BiologyProstatic Disease	2015	1.4K
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Piet Ost, Dries Reynders, Karel Decaestecker, Journal of Clinical Oncology Mdt ArmUrologySurgical OncologyOligorecurrent Prostate CancerMetastasis-directed Therapy	2017	1.3K
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial David P. Dearnaley, Isabel Syndikus, Helen Mossop, The Lancet Oncology	2016	1.3K

Page 1